Q32 Bio Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum
Q32 Bio Inc. (FIXX) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum of 3.79% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum · last filed 2026-08-05
- Q32 Bio Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for the quarter ending 2026-03-31 was 3.79%, a 15.02% decline year-over-year.
- Q32 Bio Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for the quarter ending 2025-09-30 was 3.69%, a 6.03% increase year-over-year.
- Q32 Bio Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for the quarter ending 2025-03-31 was 4.46%, a 5.19% increase year-over-year.
- Q32 Bio Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for the quarter ending 2024-09-30 was 3.48%.
- Q32 Bio Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2025 was 3.66%, a 5.17% increase from fiscal 2024.
- Q32 Bio Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2024 was 3.48%, a 3.06% decline from fiscal 2023.
- Q32 Bio Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2023 was 3.59%, a 145.89% increase from fiscal 2022.
- Q32 Bio Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2022 was 1.46%, a 192.00% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 3.79% 10-Q · filed 2026-08-05 | |||||||
| 2026-03-31 | 3.79% 10-Q · filed 2026-05-05 | |||||||
| 2025-12-31 | 3.66% 10-K · filed 2026-03-10 | |||||||
| 2025-09-30 | 3.69% 10-Q · filed 2025-11-13 | 3.69% 10-Q · filed 2025-11-13 | ||||||
| 2025-06-30 | 4.46% 10-Q · filed 2025-08-06 | |||||||
| 2025-03-31 | 4.46% 10-Q · filed 2025-05-08 | |||||||
| 2024-12-31 | 3.48% 10-K · filed 2026-03-10 | |||||||
| 2024-09-30 | 3.48% 10-Q · filed 2025-11-13 | 3.48% 10-Q · filed 2025-11-13 | ||||||
| 2024-06-30 | 4.21% 10-Q · filed 2025-08-06 | 4.21% 10-Q · filed 2025-08-06 | ||||||
| 2024-03-31 | 4.24% 10-Q · filed 2025-05-08 | |||||||
| 2023-12-31 | 3.59% 10-K · filed 2025-03-11 | 3.45% 10-K · filed 2024-03-13 | ||||||
| 2023-09-30 | 3.59% 10-Q · filed 2024-11-07 | 3.45% 10-Q · filed 2023-11-14 | ||||||
| 2023-06-30 | 3.59% 10-Q · filed 2024-08-08 | 3.45% 10-Q · filed 2023-08-14 | 3.59% 10-Q · filed 2024-08-08 | 3.45% 10-Q · filed 2023-08-14 | ||||
| 2023-03-31 | 4.06% 10-Q · filed 2023-05-11 | |||||||
| 2022-12-31 | 1.46% 10-K · filed 2024-03-13 | |||||||
| 2022-09-30 | 3.20% 10-Q · filed 2023-11-14 | 1.46% 10-Q · filed 2023-11-14 | ||||||
| 2022-06-30 | 2.67% 10-Q · filed 2023-08-14 | 1.46% 10-Q · filed 2023-08-14 | ||||||
| 2022-03-31 | 1.46% 10-Q · filed 2023-05-11 | |||||||
| 2021-12-31 | 0.50% 10-K · filed 2023-03-09 | |||||||
| 2021-09-30 | 0.81% 10-Q · filed 2022-11-10 | 0.50% 10-Q · filed 2022-11-10 | ||||||
| 2021-06-30 | 0.90% 10-Q · filed 2022-08-15 | 0.50% 10-Q · filed 2022-08-15 | ||||||
| 2021-03-31 | 0.50% 10-Q · filed 2022-05-16 | |||||||
| 2020-12-31 | 0.31% 10-K · filed 2022-03-23 | |||||||
| 2020-09-30 | 0.31% 10-Q · filed 2021-11-15 | 0.31% 10-Q · filed 2021-11-15 | ||||||
| 2020-06-30 | 0.33% 10-Q · filed 2021-08-12 | 0.33% 10-Q · filed 2021-08-12 | ||||||
| 2020-03-31 | 0.74% 10-Q · filed 2021-05-06 | |||||||
| 2019-12-31 | 1.36% 10-K · filed 2021-03-11 | |||||||
| 2019-09-30 | 1.36% 10-Q · filed 2020-11-09 | 1.36% 10-Q · filed 2020-11-09 | ||||||
| 2019-06-30 | 1.95% 10-Q · filed 2020-08-10 | 1.95% 10-Q · filed 2020-08-10 | ||||||
| 2019-03-31 | 2.48% 10-Q · filed 2020-05-07 | |||||||
| 2018-12-31 | 2.33% 10-K · filed 2020-03-12 | |||||||
| 2018-09-30 | 2.77% 10-Q · filed 2019-11-12 | 2.33% 10-Q · filed 2019-11-12 | ||||||
| 2018-06-30 | 2.33% 10-Q · filed 2019-08-08 | |||||||
| 2018-03-31 | 2.33% 10-Q · filed 2019-05-13 | |||||||
| 2017-12-31 | 2.04% 10-K · filed 2019-03-12 | |||||||
| 2017-09-30 | 1.76% 10-Q · filed 2018-11-13 | |||||||
| 2017-06-30 | 2.00% 10-Q · filed 2018-08-13 | |||||||
| 2017-03-31 | 2.22% 10-Q · filed 2018-05-14 |